Test Price
2,800 AED✅ Home Collection Available
RIPK4 Gene (Popliteal Pterygium Syndrome, Lethal Type) Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين RIPK4 (متلازمة الجناح المأبضي، النوع المميت) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
يقدم هذا الفحص الجيني المتقدم تسلسل الجيل التالي (NGS) لجين RIPK4، الضروري لتشخيص متلازمة الجناح المأبضي المميتة. بدقة تشخيصية 99.9% عبر مختبرنا المعتمد من الأيزو 9001:2015، ويشمل جمع العينات منزلياً مع استشارة هاتفية بعد النتيجة. ضمان الامتثال للمرسوم الاتحادي رقم 41 لسنة 2024 وقانون CDS 2026 للقاصرين وخصوصية البيانات. سعر 2,800 درهم.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy, available 8 AM – 11 PM daily.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-certified genetic consultant.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview / نظرة عامة
The RIPK4 gene test is a definitive NGS assay for diagnosing lethal popliteal pterygium syndrome, a rare autosomal recessive disorder characterized by webbing of skin, cleft palate, and severe craniofacial anomalies. Our UAE-based test provides unmatched precision, detecting single nucleotide variants, indels, and copy number variations across all coding exons with a turnaround time of 3–4 weeks.
| Feature | Our RIPK4 NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Methodology | NGS (Massively Parallel) | Single-capillary sequencing |
| Coverage | 100% coding exons + splice sites | Selected exons only |
| Variants Detected | SNVs, Indels, CNVs | SNVs, small indels |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | Often comparable |
| UAE DHA Compliance | Full & Certified | Varies by lab |
Physician Insight & Safety Protocol / رؤية الطبيب وبروتوكول السلامة
“As a consultant geneticist with years of experience in prenatal and pediatric dysmorphology, I emphasize that this test is a powerful tool when paired with careful clinical correlation and family history. A negative result does not rule out all genetic causes, and a positive result must be interpreted in the context of the patient’s phenotype. Never discontinue any prescribed medication or pregnancy management without direct consultation with your specialist.”
— Dr. PRABHAKAR REDDY, DHA: 61713011, Consultant Geneticist
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent allogeneic blood transfusion (<2 weeks) or severely lipemic/hemolyzed samples may be rejected; extracted DNA from buccal swab bypasses these restrictions.
- Red Flags: If the patient (especially a neonate) develops respiratory distress, severe feeding difficulties, or signs of infection at the collection site, seek immediate emergency care. This test is not a substitute for urgent clinical evaluation.
- Sample Integrity: Strict cold-chain adherence per ISO 9001:2015; any deviation during home collection must be reported to +971 54 548 8731.
UAE Regulatory Compliance & Data Privacy
This service operates under Federal Decree-Law No. 41 of 2024 (Article 87) on the use of genetic data, the UAE Child Data Safety Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All genetic information is processed in an encrypted, Dubai-based infrastructure and is never shared without explicit consent. Facility License: 9834453.
Patient FAQ & Clinical Guidance / الأسئلة الشائعة والإرشادات السريرية
1. What is the clinical utility of RIPK4 gene testing?
The confirms definitive diagnosis, guides surgical planning, and enables accurate recurrence risk counseling for families. It differentiates lethal popliteal pterygium syndrome from non-lethal forms, informs neonatal intensive care strategies, and supports early decision-making in affected pregnancies.
2. How is the sample collected and what sample types are accepted?
Home collection of blood, FTA card, or pre-extracted DNA ensures non-invasive, cold-chain compliant transport handling. Our DHA-certified phlebotomists use EDTA tubes for whole blood (2-3 mL) or sterile FTA cards requiring only a few drops; extracted DNA from a buccal swab is also welcome.
3. What is the turnaround time and what actions follow a positive result?
Results are available within 3–4 weeks; a positive result triggers immediate genetic counseling and referral. Upon detection of a pathogenic variant, our team contacts you to schedule a telephonic session with a clinical geneticist and coordinates with a pediatric dysmorphology center in UAE for further management.
Or call +971 54 548 8731 – 8 AM to 11 PM, 7 Days
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians